Related Experiment Videos
Immediate effect of various treatments on lung function in infants with cystic fibrosis
C Maayan1, E Bar-Yishay, T Yaacobi
1Department of Pediatrics, Hadassah University Hospital, Jerusalem, Israel.
Insights
Combined therapy significantly improved infant cystic fibrosis lung function. This approach, combining salbutamol and N-acetyl cysteine aerosols with chest physiotherapy, outperformed individual treatments for infants with CF.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Cystic Fibrosis Research
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting lung function in infants.
- Early intervention in CF is crucial for managing respiratory symptoms.
- Limited data exists on the immediate effects of different treatment modalities in early infancy.
Purpose of the Study:
- To assess the immediate impact of four distinct treatment regimens on lung function in infants with CF.
- To compare the efficacy of individual treatments (salbutamol, N-acetyl cysteine, chest physiotherapy) versus a combined approach.
Main Methods:
- Nineteen infants diagnosed with CF within their first year of life participated.
- Treatments included aerosolized salbutamol (SAL), N-acetyl cysteine (AC), chest physiotherapy (CPT), and a combined therapy (COMB).
- Lung function parameters (thoracic gas volume, specific airway conductance, forced expiratory flow) were measured pre- and post-therapy using whole-body plethysmography and a squeeze jacket.
Main Results:
- No significant changes in individual lung volumes were observed across any treatment group.
- Specific airway conductance (SGaw) and forced expiratory flow (VmaxFRC) showed modest but significant improvements with the COMB therapy compared to AC or CPT alone.
- Overall group analysis indicated that the combined therapy led to a significant improvement in lung function compared to any single treatment modality.
Conclusions:
- Combined aerosol therapy (salbutamol and N-acetyl cysteine) followed by chest physiotherapy demonstrates superior immediate efficacy in improving lung function parameters in infants with CF.
- This multimodal approach may offer benefits over single-modality treatments for early CF management.
- Further research is warranted to explore the long-term effects and optimal sequencing of these therapies.
Abstract:
The immediate effect of four different modes of treatment was assessed by lung function tests on 19 infants with cystic fibrosis (CF) during the first year of life. The regimens were applied in a randomized fashion and consisted of aerosol inhalation of salbutamol (n = 8; SAL), aerosol inhalation of N-acetyl cysteine (n = 5; AC), chest physiotherapy (n = 6; CPT), and combined treatment with aerosol inhalation of SAL and AC followed by CPT (n = 6; COMB). Pulmonary function was measured before and shortly after therapy with each mode of treatment. Thoracic gas volume (Vtg) and specific airway conductance (SGaw) were measured by an infant whole body plethysmograph, and forced expiratory flow at resting lung volume (VmaxFRC) was determined with a thoraco-abdominal squeeze jacket. There was no correlation between baseline lung function and changes in any parameter due to treatment. Overall group comparison showed that the combined therapy resulted in a significant improvement in lung function when compared to any of the three treatments applied separately. There was no significant change in lung volumes in any individual group, but SGaw and VmaxFRC showed a small but significant improvement following the COMB treatment when compared with AC or CPT.